| Literature DB >> 26414376 |
Mehmet Kesimer1, John Cullen2, Rui Cao1, Giorgia Radicioni1, Kyle G Mathews3, Gabriela Seiler4, Jody L Gookin3.
Abstract
Mucosal protection of the gallbladder is vital yet we know very little about the mechanisms involved. In domestic dogs, an emergent syndrome referred to as gallbladder mucocele formation is characterized by excessive secretion of abnormal mucus that results in obstruction and rupture of the gallbladder. The cause of gallbladder mucocele formation is unknown. In these first mechanistic studies of this disease, we investigated normal and mucocele-forming dog gallbladders to determine the source, identity, biophysical properties, and protein associates of the culprit mucins with aim to identify causes for abnormal mucus behavior. We established that mucocele formation involves an adoptive excess secretion of gel forming mucins with abnormal properties by the gallbladder epithelium. The mucus is characterized by a disproportionally significant increase in Muc5ac relative to Muc5b, defective mucin un-packaging, and mucin-interacting innate defense proteins that are capable of dramatically altering the physical and functional properties of mucus. These findings provide an explanation for abnormal mucus behavior and based on similarity to mucus observed in the airways of people with cystic fibrosis, suggest that abnormal mechanisms for maintenance of gallbladder epithelial hydration may be an instigating factor for mucocele formation in dogs.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26414376 PMCID: PMC4586375 DOI: 10.1371/journal.pone.0138988
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 4Changes in architecture of the gallbladder mucosa in dogs with mucocele formation.
(a) Gross appearance of the gallbladder mucosa in mucocele formation reveals copious accumulation of gelatinous mucoid content. The mucoid content transitions from pale at the base and along the length of the mucosal folds (mf) to black near the lumen (presumably due to coloration imparted by lumen bile constituents). After removal of mucus, gross photography (b), brightfield microscopy (c; hematoxylin and eosin [bar = 1,000 μm]) and scanning electron microscopy (d; bar = 200 μm) of the lumen mucosa reveals a reticular framework of mucosal folds that are more flattened, elongate and “frond-like” compared to normal gallbladder. Sub-epithelial glands are not observed (e, alcian blue pH 2.5 [bar = 50 μm]). However all epithelial cells appear to be producing mucin (f, arrow heads and linear striations of mucin extend from each individual epithelial cell into the lumen content (alcian blue pH 2.5; bar = 20 μm)). (g) Immunostaining of the gallbladder epithelium identifies PCNA positive cells that reside along the surface and base of mucosal folds (bar = 50 μm). mf–mucosal fold; PCNA–proliferating cell nuclear antigen. Figure representative of 2 to 12 dogs per imaging modality.
Results of selected clinical pathological variables assessed in 12 dogs that were diagnosed with a gallbladder mucocele and included in this study.
| Clinical Pathological Variable | Median | Range | Number (%) of dogs with abnormal value | Reference range |
|---|---|---|---|---|
|
| ||||
| Packed cell volume (%) | 39 | 26–51 | 6/12 (50) | 39–58 |
| Plasma protein (g/dl) | 7.1 | 4.3–10 | 7/12 (58) | 6.1–7.5 |
| Polymorphonuclear leukocytes (× 103/μl) | 12.605 | 4.181–30.628 | 7/12 (58) | 2.841–9.112 |
| Bands (× 103/μl) | 161 | 0–5.281 | 8/12 (67) | 0.0–0.0 |
| Immature granulocytes (× 103/μl) | 0 | 0–270 | 1/12 (8) | 0.0–0.0 |
| Platelets (× 103/μl) | 315 | 70–937 | 5/12 (42) | 191–468 |
|
| ||||
| Alkaline phosphatase (IU/L) | 968 | 24–5575 | 10/12 (83) | 16–140 |
| Alanine transaminase (IU/L) | 491 | 20–1403 | 11/12 (92) | 12–54 |
| Gamma-glutamyl transferase (IU/L) | 29 | 0–282 | 10/12 (83) | 0–6 |
| Total bilirubin (mg/dl) | 0.6 | 0–11.2 | 7/12 (58) | 0–0.2 |
| Cholesterol (mg/dl) | 366 | 148–875 | 7/12 (58) | 124–344 |
| Lipase (IU/L) | 103 | 16–2332 | 4/12 (33) | 12–147 |
| Amylase (IU/L) | 700 | 281–4817 | 2/12 (17) | 236–1337 |
Differential expression of proteins associated with the large polymeric mucin-rich fraction of mucus isolated from normal compared to mucocele gallbladders as determined by mass spectrometry.
| Protein Description (access gi#[Canis lupus familiaris] and name) | Average Total Intensity | Fold Increase | t test p-value | |
|---|---|---|---|---|
| Normal (n = 4) | Mucocele (n = 4) | |||
|
| ||||
| gi|359321890 Mucin-5ac | 6.883E+8 | 1.148E+10 | 16.6 | 0.012 |
| gi|345783652 Mucin-5b | 2.905E+10 | 7.015E+10 | 2.5 | 0.163 |
| Ratio mucin-5ac/5b | 2.37E-2 | 16.36E-2 | 6.9 | 0.048 |
| gi|359318821 IgGFc-binding protein | 1.383E+10 | 3.251E+11 | 23.5 | >0.0001 |
| gi|345792551 Deleted in malignant brain tumors 1 protein | 6.912E+7 | 1.576E+9 | 22.8 | >0.0001 |
| gi|156875884 Trefoil factor family peptide 3 | 2.070E+8 | 3.438E+9 | 16.6 | 0.003 |
| gi|345802838 Polymeric immunoglobulin receptor | 1.923E+9 | 2.232E+10 | 11.6 | 0.0028 |
| gi|73953129 Pulmonary surfactant-associated protein D isoform 1 | Nd | 6.103E+8 | 0.036 | |
| gi|73964953 Galectin-3-binding protein | Nd | 2.019E+7 | 0.036 | |
|
| ||||
| gi|345779666 Ig J chain isoform 1 | 3.982E+8 | 1.093E+10 | 27.4 | >0.0001 |
| gi|124390009 IgM heavy chain constant region CH2 | 7.521E+7 | 1.729E+9 | 23.0 | 0.015 |
| gi|124390007 IgM heavy chain constant region CH1 | 2.653E+7 | 6.094E+8 | 23.0 | 0.015 |
| gi|164452882 Ig kappa light chain variable region | 2.980E+7 | 5.174E+8 | 17.4 | 0.015 |
| gi|208342271 Ig heavy chain variable region, partial | 9.906E+6 | 1.460E+8 | 14.7 | 0.04 |
| gi|208342106 Ig heavy chain variable region, partial | 1.428E+7 | 8.151E+7 | 5.7 | 0.052 |
| gi|1096664 IgA heavy chain constant region | 6.781E+9 | 2.887E+10 | 4.3 | 0.0019 |
|
| ||||
| gi|359322249 Complement C3 | 2.426E+8 | 2.302E+9 | 9.5 | 0.002 |
| gi|359320893 Complement C4-A | 2.753E+7 | 2.371E+8 | 8.6 | 0.02 |
| gi|73997271| Complement C1r subcomponent isoform1 | Nd | 8.884E+7 | 0.039 | |
| gi|345803075 C4b-binding protein alpha chain | Nd | 4.308E+7 | 0.109 | |
| gi|74002140 Complement factor I isoform 3 | Nd | 3.242E+7 | 0.11 | |
| gi|57091989 Complement component C8 gamma chain | Nd | 2.550E+6 | 0.122 | |
| gi|73997275 Complement C1s subcomponent isoform 2 | Nd | 3.368E+7 | 0.134 | |
| gi|74005944 Complement factor H isoform 2 | Nd | 2.550E+6 | 0.15 | |
|
| ||||
| gi|119637732 Alpha-1 antitrypsin | 7.713E+6 | 2.820E+8 | 36.5 | 0.0017 |
| gi|73946216 Plasminogen | 6.065E+6 | 1.419E+8 | 23.4 | 0.005 |
| gi|73964432 Alpha-1-antichymotrypsin | 5.411E+6 | 9.483E+7 | 17.5 | 0.0087 |
| gi|73967363 Alpha-2-antiplasmin isoform 2 | Nd | 2.309E+7 | 0.029 | |
|
| ||||
| gi|73988725 Hemopexin | 3.410E+7 | 1.110E+9 | 32.5 | 0.005 |
| gi|22531688 Serum albumin | 1.544E+9 | 1.242E+10 | 8.0 | 0.01 |
| gi|345781768 Fibrinogen-like 1 | 6.725E+6 | 3.330E+7 | 5.0 | 0.008 |